Dr. Reddy's Laboratories
150 hedge funds and large institutions have $816M invested in Dr. Reddy's Laboratories in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 19 closing their positions.
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
22% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 45
12% more call options, than puts
Call options by funds: $277K | Put options by funds: $247K
5% more funds holding
Funds holding: 143 → 150 (+7)
1.83% more ownership
Funds ownership: 63.69% → 65.53% (+1.8%)
5% less capital invested
Capital invested by funds: $856M → $816M (-$41M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Natixis
Paris,
France
|
+$16.6M |
| 2 |
BAMCO Inc
New York
|
+$11.2M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.25M |
| 4 |
BlackRock
New York
|
+$7.07M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$12.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.78M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.65M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$5.26M |
| 5 |
CLC
Charles-Lim Capital
Central,
Hong Kong
|
-$4.96M |
RDY Hedge Fund Activity: Q2 2019 in Review
150 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2019, worth a combined $816M — down 4.8% from $856M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new RDY positions and 19 closed out — a net gain of 7 holders — while 55 added to existing stakes and 45 trimmed.
The largest buyer was Natixis, opening a new position worth an estimated $16.6M. The largest seller was DZ Bank, cutting an estimated $12.4M.
- 150 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2019, up from 143 in Q1 2019.
- Funds reported $816M of Dr. Reddy's Laboratories stock for Q2 2019, down 4.8% quarter-over-quarter.
- 26 funds opened new Dr. Reddy's Laboratories positions in Q2 2019 and 19 closed out, a net change of +7 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2019 was Natixis, an estimated $16.6M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2019 was DZ Bank, an estimated $12.4M sold.
Based on aggregated 13F filings for Q2 2019.